Patient Recruitment Resumes in FibroGen Phase 2 Study of ... - Earthtimes (press release) PDF Print

In fact, only 5% of incident dialysis patients have received therapy with Erythropoiesis-Stimulating Agents (ESAs), the primary treatment for anemia of CKD, ...

read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129